DOI: 10.18297/etd/1618
|View full text |Cite
|
Sign up to set email alerts
|

Adriamycin nephrotoxicity is reduced by metallothionein over-expression and kidney gene expression is modified by diabetes in the OVE26 diabetic model.

Abstract: Yang, Lu, "Adriamycin nephrotoxicity is reduced by metallothionein over-expression and kidney gene expression is modified by diabetes in the OVE26 diabetic model." (2010 This thesis is divided into two parts below.Part I Adriamycin (ADR) can produce nephrotoxicity in rodents. The underlying mechanism may relate to ADR induced oxidative stress. In this study, we used transgenic mice (NMT3), which over-expressed the antioxidant protein metallothionein (MT) in podocytes, to study MT's protective potential on ADR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 80 publications
(103 reference statements)
1
2
0
Order By: Relevance
“…For female mice, plasma insulin levels in OVE26 mice significantly reduced after 4 weeks old. Still a low level of insulin exists in OVE26 mice, the results are similar to previous reports …”
Section: Resultssupporting
confidence: 92%
See 1 more Smart Citation
“…For female mice, plasma insulin levels in OVE26 mice significantly reduced after 4 weeks old. Still a low level of insulin exists in OVE26 mice, the results are similar to previous reports …”
Section: Resultssupporting
confidence: 92%
“…Still a low level of insulin exists in OVE26 mice, the results are similar to previous reports. 5,6,19…”
Section: Type 1 Diabetes Did Not Induce Lipids Deposition In Ove26 Mi...mentioning
confidence: 99%
“…Diabetic nephropathy (DN) is the changes in chronic kidney structure and dysfunction caused by diabetes, which has become the leading cause of chronic kidney disease and end-stage renal disease [ 1 ]. According to statistics from the International Diabetes Federation (IDF), the number of diabetes patients worldwide in 2015 was 415 million, and it is expected to increase to 552 million in 2035 [ 2 ].…”
Section: Introductionmentioning
confidence: 99%